N-(benzo[d]thiazol-2-yl)-2-((6,8-dimethyl-5,7-dioxo-2-(thiophen-2-yl)-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-4-yl)thio)acetamide structure
|
Common Name | N-(benzo[d]thiazol-2-yl)-2-((6,8-dimethyl-5,7-dioxo-2-(thiophen-2-yl)-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-4-yl)thio)acetamide | ||
|---|---|---|---|---|
| CAS Number | 847192-01-2 | Molecular Weight | 496.6 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H16N6O3S3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | N-(benzo[d]thiazol-2-yl)-2-((6,8-dimethyl-5,7-dioxo-2-(thiophen-2-yl)-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-4-yl)thio)acetamide |
|---|
| Molecular Formula | C21H16N6O3S3 |
|---|---|
| Molecular Weight | 496.6 |
| InChIKey | VCXRUUBXBCTNRX-UHFFFAOYSA-N |
| SMILES | CN1C2=C(C(=NC(=N2)C3=CC=CS3)SCC(=O)NC4=NC5=CC=CC=C5S4)C(=O)N(C1=O)C |
|
Name: Inhibitors of CDC25B-CDK2/CyclinA interaction
Source: Center for Chemical Genomics, University of Michigan
External Id: MScreen:TargetID_600
|